customer.service@microbix.com 
NEWS RELEASES
Microbix Annual General Meeting (AGM) Update
Remote Access to the AGM Provided to Avoid Physical Attendance MISSISSAUGA, CANADA, March 22, 2023 - Microbix Biosystems Inc. (TSX: MBX,...
Governments of Ontario and Canada Invest in Microbix
$ 1.68 Million in Funding for Capabilities and Capacity Expansions MISSISSAUGA, CANADA, March 20, 2023 – Microbix Biosystems Inc. (TSX:...
Microbix Supporting Australian Point-of-Care Testing Program
QAPs used in Diagnostic Testing for STIs in Remote Communities MISSISSAUGA, CANADA, March 1, 2023 – Microbix Biosystems Inc. (TSX: MBX,...
Microbix Announces Issuance of Stock Options
Using Shareholder-Approved Plan to Incentivize and Retain MISSISSAUGA, CANADA, February 27, 2023 - Microbix Biosystems Inc. (TSX: MBX,...
Microbix Reports Results for Q1 Fiscal 2023
Sales of $2.5 million, Net Loss of $1.3 million MISSISSAUGA, February 9, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF,...
Microbix Presenting Results of Collaboration with Health PEI
QAPs for HPV Test Verification within Cervical Cancer Screening Program MISSISSAUGA, CANADA, February 6, 2023 – Microbix Biosystems Inc....
Microbix Launches QAP to Support “Monkeypox” Testing
Driven by Customer Requests, Mpox Test Control Now Available MISSISSAUGA, CANADA, January 30, 2023 – Microbix Biosystems Inc. (TSX: MBX,...
Microbix Reports Record Sales for Fiscal 2022
Record Sales of $19.1 million, Net Earnings of $1.8 million MISSISSAUGA, December 22, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Microbix Presenting Test-Workflow Validation Results at EMMD
MSwab® & PROCEEDx™FLOQ® Supporting Self-Collection for HPV Screening Programs MISSISSAUGA, CANADA, October 6, 2022 – Microbix...
Microbix Announces Initiation of Normal Course Issuer Bid
Microbix to Repurchase up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, September 28, 2022 – Microbix Biosystems...
Microbix Presenting at Muskoka Capital Conference
Meetings with Growth-Oriented Investors, September 23-25, 2022 MISSISSAUGA, CANADA, September 21, 2022 - Microbix Biosystems Inc. (TSX:...
Microbix Reports Results for Q3 Fiscal 2022
Q3 Sales of $5.0 million, Q3 Net Earnings of $0.6 million MISSISSAUGA, August 11, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF,...
